Public Title Status Last Date Modified
A Phase III, Randomized, Open-Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab a . . . Ongoing 18 May 2020
A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine + Cisplatin for Neoadjuvant Treatment Followed by Dur . . . Ongoing 19 May 2020
A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab Given Concurrently with Platinum-based Chemoradiation Therapy in Patients with Locally Advanc . . . Ongoing 18 May 2020
A Phase IV Interventional Safety, Efficacy and Quality of Life Study of ELIGARD® in Prostate Cancer Patients in Asia (ELIGANT) . . . Completed 05 Nov 2020
A prospective, open-label, interventional phase IV study to assess the safety of EupentaTM Inj. {fully liquid pentavalent vaccine, Adsorbed Diphtheria-Tetanus-whole-cell Pertussis-Hepatitis B (rDNA [r . . . Ongoing 14 May 2020
A prospective, Phase I, randomized, controlled, open label study to assess the reactogenicity, safety and immunogenicity of a combined liquid DTwP-rHepB-Hib-IPV vaccine when administered to healthy ch . . . Completed 02 Aug 2019
A randomized double-blind, placebo-controlled, multicenter trial assessing the impact of lipoprotein (a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular . . . Pending 09 Sep 2020
A Randomized, Controlled Double-blind Study Comparing the Efficacy and Safety of Orelvo (voclosporin) (23.7 mg Twice Daily) with Placebo in Achieving Renal Response in Subjects with Active Lupus Nephr . . . Completed 02 Mar 2020
A Randomized, Controlled, Double-blind, Continuation Study Comparing the Long-term Safety and Efficacy of Orelvo (voclosporin) (23.7 mg Twice Daily) with Placebo in Subjects with Lupus Nephritis . . . Ongoing 02 Mar 2020
A Randomized, Double-blind, Event-driven, Placebo-controlled, Multicenter Study of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Subjects With Type 2 Diabetes Mellitus and Diabe . . . Completed 23 Sep 2019
A Randomized, Double-blind, Multi-center, Multi-national Trial to Evaluate the Efficacy,  Safety, and Immunogenicity of SAIT101 Versus Rituximab as a First-line Immunotherapy Treatment in Patients wi . . . Ongoing 03 Jul 2020
A randomized, double-blind, multicenter study assessing short (16 weeks) and long-term efficacy (up to 1 year), safety, and tolerability of 2 subcutaneous secukinumab dose regimens in adult patient . . . Ongoing 07 Jan 2020
A randomized, double-blind, multicenter study assessing short (16 weeks) and long-term efficacy (up to 1 year), safety, and tolerability of 2 subcutaneous secukinumab dose regimens in adult patient . . . Ongoing 07 Jan 2020
A Randomized, Double-blind, Parallel Group, Equivalence, Multicenter Phase III Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in patients with Metasta . . . Ongoing 09 Sep 2020
A Randomized, Double-Blind, Placebo-Controlled 52-Week Study to Assess Adverse Events of Special Interest in Adults with Active, Autoantibody-Positive Systemic Lupus Erythematosus Receiving Belimumab . . . Ongoing 10 Oct 2019
A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in Asian subjects (≥16 to 80 years of age) with parti . . . Ongoing 11 Aug 2020
A randomized, double-blind, placebo-controlled, parallel group, multi-center trial of pregabalin as adjunctive therapy in pediatric and adult subjects with primary generalized tonic-clonic seizures . . . Completed 17 Jul 2019
A randomized, double-blind, placebo-controlled, parallel group, phase III multicenter study of intravenous secukinumab to compare efficacy at 16 weeks with placebo and to assess safety and tolerabilit . . . Ongoing 30 Jul 2020
A Randomized, Double-blind, Placebo-controlled, Phase Ib/II Clinical Study to Evaluate the Preliminary Efficacy, Safety, Pharmacokinetic Profiles and Immunogenecity of JS016 (Recombinant Human Anti-SA . . . Pending 01 Oct 2020
A Randomized, Double-blinded, Multicenter, Phase III Clinical Study of HLX10 (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Injection) Combined with Chemotherapy versus Placebo with Chemotherapy . . . Pending 12 Aug 2020
A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (≥10to . . . Ongoing 14 Aug 2020
A Randomized, Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Acalabrutinib versus Chlorambucil plus Rituximab in Subjects with Previously Untreated Chronic Lymphocytic L . . . Pending 12 May 2020
A randomized, observer blinded, controlled trial to evaluate the safety and immunogenicity of a new formulation of Euvichol® (killed bivalent (O1 and O139) whole cell oral cholera vaccine (WC-OCV) ma . . . Completed 22 Apr 2019
A Randomized, Open Label Phase III Study to Evaluate the Efficacy and Safety of Oral Afatinib (BIBW 2992) versus Intravenous Methotrexate in Patients with Recurrent and/or Metastatic Head and Neck Squ . . . Completed 01 Jul 2019
A Regional, Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Severe Uncontrolled Asthma . . . Ongoing 26 Nov 2020

Copyright © One Window Project 2020. All rights reserved.